← All candidates
78 insider filings on record.
78 filings on record.
APGEApogee Therapeutics, Inc.
NASDAQ · Healthcare · $10.22B
$135.07
+0.00% · Sep 3
78 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 58 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$10.22B
Float
58.4M
94% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
4 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
73 more transactions on Pro →Context
Wall St
$130.53 avg target
-3.4% vs today · 12 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$1.06 act+$0.07
Q4 '25−$1.03 act+$0.01
Q3 '25−$1.11 act+$0.04
Q2 '25−$1.13 act−$0.08
Coverage
AbbVie (ABBV) to Acquire Apogee TherapeuticsInsider Monkey · 06-27Is AbbVie a Buy After Its Purchase of Apogee?Motley Fool · 06-25Canaccord Says AbbVie’s (ABBV) Apogee Deal Strengthens Long-Term Growth OutlookInsider Monkey · 06-25What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?Zacks · 06-30
The file stays open
78 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice